Kurs
+3,27%
Kurs
+3,27%
Open
19,91
High
19,91
Low
17,55
Close
19,27
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
Tid* | ||
2025-06-25 | N/A | Årsstämma |
2025-03-05 | 06:00 | Bokslutskommuniké 2024 |
2024-12-20 | N/A | Extra Bolagsstämma 2024 |
2024-11-27 | - | Kvartalsrapport 2024-Q3 |
2024-09-12 | - | Kvartalsrapport 2024-Q2 |
2024-06-28 | - | Kvartalsrapport 2024-Q1 |
2024-06-27 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2024-06-26 | - | Årsstämma |
2024-03-20 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-09-26 | - | Kvartalsrapport 2023-Q2 |
2023-06-21 | - | Årsstämma |
2023-06-21 | - | Kvartalsrapport 2023-Q1 |
2023-03-30 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-12-09 | - | Extra Bolagsstämma 2022 |
2022-10-26 | - | Kvartalsrapport 2022-Q3 |
2022-08-15 | - | Kvartalsrapport 2022-Q2 |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-04-19 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2022-04-17 | - | Årsstämma |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-12-29 | - | Extra Bolagsstämma 2021 |
2021-11-17 | - | Kvartalsrapport 2021-Q3 |
2021-09-08 | - | Kvartalsrapport 2021-Q2 |
2021-04-29 | - | Kvartalsrapport 2021-Q1 |
2021-04-14 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2021-04-13 | - | Årsstämma |
2021-02-09 | - | Bokslutskommuniké 2020 |
2020-12-14 | - | Kvartalsrapport 2020-Q3 |
2020-09-30 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2020-06-30 | - | Årsstämma |
2020-06-30 | - | Kvartalsrapport 2020-Q1 |
2019-12-20 | - | Extra Bolagsstämma 2019 |
2019-06-27 | - | Årsstämma |
2019-06-03 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2018-07-02 | - | Split SOFTX 1:50 |
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-11-03 14:07:14
Oslo, Norway, November 3, 2022: Geir H. Almås, CEO of SoftOx Solutions AS, a
person discharging managerial responsibilities in SoftOx Solutions AS (the
"Company"), has notified the Company of a transfer of a part of the convertible
loan issued by the Company, as announced on October 11 2022.
Please refer to the attached form for further details about the transfer.
For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Rød of SoftfOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599
The information included in this announcement is defined as inside information
pursuant to MAR article 7, and is publicly disclosed in accordance with MAR
article 17. The announcement is made by the contact person.
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
biopharmaceutical and MedTech company based in Oslo, with the goal of reducing
the spread of infection and emergence of antimicrobial resistance. For more
information on SoftOx, visit www.soft-ox.com